ATE305793T1 - Bakteriophage mit breitem wirtspektrum - Google Patents
Bakteriophage mit breitem wirtspektrumInfo
- Publication number
- ATE305793T1 ATE305793T1 AT01955955T AT01955955T ATE305793T1 AT E305793 T1 ATE305793 T1 AT E305793T1 AT 01955955 T AT01955955 T AT 01955955T AT 01955955 T AT01955955 T AT 01955955T AT E305793 T1 ATE305793 T1 AT E305793T1
- Authority
- AT
- Austria
- Prior art keywords
- bacteriophage
- broad host
- host spectrum
- spectrum
- broad
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/14011—Details ssDNA Bacteriophages
- C12N2795/14211—Microviridae
- C12N2795/14232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22098700P | 2000-07-25 | 2000-07-25 | |
PCT/US2001/023390 WO2002007742A2 (en) | 2000-07-25 | 2001-07-25 | Bacteriophage having multiple host range |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE305793T1 true ATE305793T1 (de) | 2005-10-15 |
Family
ID=22825862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01955955T ATE305793T1 (de) | 2000-07-25 | 2001-07-25 | Bakteriophage mit breitem wirtspektrum |
Country Status (8)
Country | Link |
---|---|
US (1) | US7163818B2 (de) |
EP (1) | EP1305038B1 (de) |
AT (1) | ATE305793T1 (de) |
AU (1) | AU2001278003A1 (de) |
CA (1) | CA2417188A1 (de) |
DE (1) | DE60113851T2 (de) |
ES (1) | ES2252263T3 (de) |
WO (1) | WO2002007742A2 (de) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6121036A (en) * | 1996-04-15 | 2000-09-19 | Ghanbari; Hossein A. | Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
ES2322556T3 (es) | 2001-06-15 | 2009-06-23 | PRYSMIAN CABLES & SYSTEMS LIMITED | Conexion de fibras opticas. |
JP4723807B2 (ja) * | 2001-07-18 | 2011-07-13 | インスティチュート イムノロジー アイ テラピー ドスウィアドクツァルネジ パン | 細菌感染を治療するための多価バクテリオファージの調製方法 |
GB0209680D0 (en) | 2002-04-27 | 2002-06-05 | Univ Strathclyde | Immobilisation and stabilisation of bacteriophage |
US7588929B2 (en) | 2002-12-09 | 2009-09-15 | Phage Biopharm Llc | Production of bacteriophage compositions for use in phage therapy |
GB0300597D0 (en) | 2003-01-10 | 2003-02-12 | Microbiological Res Authority | Phage biofilms |
US7951579B2 (en) * | 2003-04-07 | 2011-05-31 | Board of Trutees of the University of Arkansas | Method for bacteriophage delivery and amplification |
EP2570130B1 (de) | 2003-07-23 | 2014-11-26 | Biocontrol Limited | Bakteriophagen gegen P. aeruginosa enhaltende therapeutische Wirkstoffe |
GB0320838D0 (en) | 2003-09-05 | 2003-10-08 | Univ Nottingham | Disinfection of foodstuffs |
WO2006063176A2 (en) * | 2004-12-06 | 2006-06-15 | The Government Of The Usa As Representedtd By The Secretary Of The Dept Of Health And Human Services | Inhibition of biofilm formation using bacteriophage |
WO2006066224A2 (en) * | 2004-12-14 | 2006-06-22 | Yale University | Virulence targeted antibiotics |
CA2495138C (en) * | 2005-01-20 | 2012-10-23 | Alison Jane Basile | Multiplexed analysis for determining a serodiagnosis of viral infection |
EP1855723B1 (de) * | 2005-03-08 | 2013-05-22 | Ramot at Tel-Aviv University Ltd. | Zielgerichtete arzneistofftragende bakteriophagen |
JP5127708B2 (ja) * | 2005-07-12 | 2013-01-23 | マイクレオス べスローテン フェンノートシャップ | バクテリオファージ及びその使用 |
US20090053179A1 (en) * | 2005-10-05 | 2009-02-26 | Internalle, Inc. | Method for using liberated dormant bacteriophage and environmental stress to reduce infectious bacteria |
CA2648232A1 (en) | 2006-04-04 | 2007-10-11 | Centre National De La Recherche Scientifique - Cnrs | Process of production of bacteriophage compositions and methods in phage therapy field |
KR100781669B1 (ko) * | 2006-06-20 | 2007-12-03 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균 특이적 사멸능을 갖는 박테리오파지 |
KR100759988B1 (ko) * | 2006-08-04 | 2007-09-19 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균에 특이적인 항균 단백질 |
FR2910493B1 (fr) * | 2006-12-20 | 2012-12-14 | Bio Modeling Systems Ou Bmsystems | Procede de diversification aleatoire d'une sequence genetique permettant de preserver l'identite de certains segments internes de ladite sequence genetique |
FR2910492B1 (fr) * | 2006-12-20 | 2013-02-15 | Bio Modeling Systems Ou Bmsystems | Procede de preparation de bacteriophages modifies par insertion de sequences aleatoires dans les proteines de ciblage desdits bacteriophages |
GB0704553D0 (en) | 2007-03-09 | 2007-04-18 | Harper David R | Beneficial effects of bacteriophage treatments |
EP2145015A4 (de) * | 2007-03-30 | 2012-02-29 | Ca Nat Research Council | Phagenrezeptorbindende proteine für antibakterielle therapie und andere neuartige verwendungen |
KR100910961B1 (ko) * | 2007-09-13 | 2009-08-05 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균의 균막 처치에 효과적인 박테리오파지 또는그것 유래의 용균단백질 |
US20100092431A1 (en) * | 2008-05-15 | 2010-04-15 | Auburn University | Edwardsiella Ictaluri Bacteriophage and Uses Thereof |
US8377866B2 (en) * | 2009-02-12 | 2013-02-19 | Intron Biotechnology, Inc. | Antimicrobial protein derived from Podoviridae bacteriophage specific to Staphylococcus aureus |
WO2012145676A1 (en) * | 2011-04-20 | 2012-10-26 | Dcb-Usa Llc | Polypeptides and bacteriophages specific to klebsiella pneumoniae capsular type strains |
WO2013010660A1 (en) * | 2011-07-15 | 2013-01-24 | Medizinische Hochschule Hannover (Mhh) | Enzymes having alpha2,9 endosialidase activity |
RU2518303C2 (ru) * | 2012-06-29 | 2014-06-10 | Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии имени Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН МНИИЭМ им. Г.Н. Габричевского Роспотребнадзора) | КОМПОЗИЦИЯ АНТИБАКТЕРИАЛЬНАЯ, ШТАММ БАКТЕРИОФАГА Escherichia coli, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ ТАКОЙ КОМПОЗИЦИИ. |
US9617522B2 (en) | 2013-09-05 | 2017-04-11 | Massachusetts Institute Of Technology | Tuning bacteriophage host range |
EP2893933A1 (de) * | 2014-01-10 | 2015-07-15 | Pherecydes Pharma | Phagentherapie von E.coli-Infektionen |
GB201417808D0 (en) | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modified bacteriophage |
GB201417810D0 (en) | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modifying bacteriophage |
GB201417811D0 (en) * | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modifying bacteriophage |
GB201417805D0 (en) | 2014-10-08 | 2014-11-19 | Phico Therapeutics Ltd | Modifield bacteriophage |
EP3018201A1 (de) | 2014-11-07 | 2016-05-11 | Pherecydes Pharma | Phagentherapie |
WO2016100389A1 (en) * | 2014-12-16 | 2016-06-23 | Synthetic Genomics, Inc. | Compositions of and methods for in vitro viral genome engineering |
PT3440200T (pt) | 2016-04-08 | 2021-04-30 | Phico Therapeutics Ltd | Bacteriófago modificado |
CA3020371A1 (en) | 2016-04-08 | 2017-10-12 | Phico Therapeutics Ltd. | Modifying bacteriophage |
EP3532850A1 (de) | 2016-10-28 | 2019-09-04 | Massachusetts Institute Of Technology | Synthetische bakteriophagen und bakteriophagenzusammensetzungen |
KR101822812B1 (ko) * | 2017-02-22 | 2018-01-29 | 주식회사 인트론바이오테크놀로지 | 신규한 엔테로코쿠스 패슘 박테리오파지 Ent-FAP-4 및 이의 엔테로코쿠스 패슘 증식 억제 용도 |
US10174295B1 (en) | 2017-08-01 | 2019-01-08 | The Charles Stark Draper Laboratory, Inc. | Composition of matter: engineering of Escherichia coli phage K1E |
GB201712733D0 (en) | 2017-08-08 | 2017-09-20 | Snipr Tech Ltd | Methods & cells |
CN111788304A (zh) * | 2018-01-19 | 2020-10-16 | 噬菌体技术公司 | 基因工程噬菌体 |
GB201901099D0 (en) | 2019-01-27 | 2019-03-13 | Snipr Biome Aps | Methods, uses and compositions |
AU2020312725A1 (en) * | 2019-07-18 | 2022-03-03 | Technische Universität München | Host-independent expression of bacteriophages |
CN112695017B (zh) * | 2019-10-23 | 2022-04-15 | 吉林大学 | 噬菌体vB_Yen_X1及在防治鼠疫杆菌感染中应用 |
US11584781B2 (en) | 2019-12-30 | 2023-02-21 | Eligo Bioscience | Chimeric receptor binding proteins resistant to proteolytic degradation |
CN111876400B (zh) * | 2020-08-06 | 2022-05-24 | 昆明理工大学 | 一种常温裂解酶Sly和编码此酶的多核苷酸 |
CN112143747B (zh) * | 2020-09-09 | 2022-09-13 | 昆明理工大学 | 一种噬菌体裂解酶及其基因、基因重组表达载体与应用 |
CN113215114A (zh) * | 2021-06-09 | 2021-08-06 | 西南石油大学 | 一种ndm-1大肠杆菌噬菌体及其分离方法和应用 |
WO2024003301A1 (en) | 2022-06-29 | 2024-01-04 | Snipr Biome Aps | Targeting e coli cells |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4405720A (en) * | 1981-03-04 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | Silver stains for protein in gels |
US4508820A (en) * | 1982-08-13 | 1985-04-02 | The United States Of America As Represented By The Department Of Health And Human Services | Method for simultaneously monitoring turnover rate in multiple proteins |
US4555490A (en) * | 1984-06-08 | 1985-11-26 | The United States Of America As Represented By The Department Of Health And Human Services | Rapid visualization system for gel electrophoresis |
US4703016A (en) * | 1986-05-05 | 1987-10-27 | The United States Of America As Represented By The Department Of Health And Human Services | Silver stain for rapid, quantitative detection of polypeptides and nucleic acids |
US4940659A (en) * | 1987-02-20 | 1990-07-10 | Monoclonetics International, Inc. | Screening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndrome |
US4892814A (en) * | 1987-06-22 | 1990-01-09 | The United States Of America As Represented By The Department Of Health And Human Services | Method for distinguishing Creutzfeldt-Jakob disease from other dementias |
US5817797A (en) * | 1988-06-01 | 1998-10-06 | The United States Of America As Represented By The Department Of Health And Human Services | Sequencing DNA; a modification of the polymerase chain reaction |
US5292665A (en) * | 1989-03-15 | 1994-03-08 | The United States Of America As Represented By The Department Of Health And Human Services | Catalyst for preparing polyacrylamide gel which improves the detection of biomaterials by silver staining |
DK0559795T3 (da) * | 1990-11-30 | 1996-01-29 | Monoclonetics Int | Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen |
US5844097A (en) * | 1990-11-30 | 1998-12-01 | Monoclonetics International, Inc. | Methods for the diagnosis of peripheral nerve damage |
US5378602A (en) * | 1991-05-29 | 1995-01-03 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Highly informative microsatellite repeat polymorphic DNA markers twenty-[seven]six |
US5861504A (en) * | 1991-05-29 | 1999-01-19 | The United States Of America As Represented By The Department Of Health And Human Services | Eleven highly informative microsatelite repeat polymorphic DNA markers |
US5468610A (en) * | 1991-05-29 | 1995-11-21 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Three highly informative microsatellite repeat polymorphic DNA markers |
US5429947A (en) * | 1992-06-17 | 1995-07-04 | Merril; Carl R. | Diagnosing Alzheimer's disease and schizophrenia |
US20010043924A1 (en) * | 1994-04-05 | 2001-11-22 | Exponential Biotherapies, Inc. | Antibacterial therapy with bacteriophage physico-chemically altered to delay inactivation by the host defense system |
US5811093A (en) * | 1994-04-05 | 1998-09-22 | Exponential Biotherapies, Inc. | Bacteriophage genotypically modified to delay inactivations by the host defense system |
AU699322B2 (en) * | 1994-04-05 | 1998-12-03 | Exponential Biotherapies, Inc. | Antibacterial therapy with genotypically modified bacteriophage |
US5736388A (en) * | 1994-12-30 | 1998-04-07 | Chada; Sunil | Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells |
SE506771C2 (sv) * | 1996-02-06 | 1998-02-09 | Gotpat 105 Ab | Fusionsprotein, bakteriofag uttryckande proteinet, dessas användning samt hybridoma celler och monoklonaler producerade av cellerna |
WO1998005344A1 (en) * | 1996-08-05 | 1998-02-12 | Brigham And Women's Hospital, Inc. | Bacteriophage-mediated gene therapy |
US20020177614A1 (en) * | 2001-03-23 | 2002-11-28 | Merril Carl R. | Methods for treating nuerodegenerative diseases including alzheimer's |
US7521479B2 (en) * | 2001-04-16 | 2009-04-21 | Panacea Pharmaceuticals, Inc. | Methods of treating prion disease in mammals |
EP1543169A4 (de) * | 2002-01-23 | 2007-09-12 | Us Gov Health & Human Serv | Verfahren zur bestimmung der empfindlichkeit gegenüber bakteriophagen |
US7399753B2 (en) * | 2002-02-25 | 2008-07-15 | Virxsys Corporation | Trans-splicing mediated photodynamic therapy |
-
2001
- 2001-07-25 DE DE60113851T patent/DE60113851T2/de not_active Expired - Lifetime
- 2001-07-25 CA CA002417188A patent/CA2417188A1/en not_active Abandoned
- 2001-07-25 EP EP01955955A patent/EP1305038B1/de not_active Expired - Lifetime
- 2001-07-25 AU AU2001278003A patent/AU2001278003A1/en not_active Abandoned
- 2001-07-25 WO PCT/US2001/023390 patent/WO2002007742A2/en active IP Right Grant
- 2001-07-25 AT AT01955955T patent/ATE305793T1/de not_active IP Right Cessation
- 2001-07-25 ES ES01955955T patent/ES2252263T3/es not_active Expired - Lifetime
-
2003
- 2003-01-21 US US10/350,256 patent/US7163818B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2002007742A2 (en) | 2002-01-31 |
EP1305038B1 (de) | 2005-10-05 |
EP1305038A2 (de) | 2003-05-02 |
WO2002007742A9 (en) | 2002-04-18 |
DE60113851T2 (de) | 2006-07-20 |
ES2252263T3 (es) | 2006-05-16 |
CA2417188A1 (en) | 2002-01-31 |
AU2001278003A1 (en) | 2002-02-05 |
US20030216338A1 (en) | 2003-11-20 |
WO2002007742A3 (en) | 2002-08-08 |
WO2002007742A8 (en) | 2003-10-30 |
US7163818B2 (en) | 2007-01-16 |
DE60113851D1 (de) | 2006-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE305793T1 (de) | Bakteriophage mit breitem wirtspektrum | |
DE60334016D1 (de) | Antibakterielle mittel | |
TW200507841A (en) | Antibacterial agents | |
CY1105349T1 (el) | Θειαζολυλ-αναστολεις τυροκινασεων της οικογενειας tec | |
ATE340171T1 (de) | Piperazinderivate zur behandlung bakterieller infektionen | |
DE60307860D1 (de) | Aminocyclohexenchinoline und ihre azaisosterischen analoga mit antibakterieller wirkung | |
HUP0400446A2 (hu) | Azitromicin kristályformái | |
EP1560821B8 (de) | Antibakterielle wirkstoffe | |
ATE354585T1 (de) | Antibakterielle amid-makrozyklen | |
DE69835536D1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
WO2003099217A3 (en) | Methods of treating bacterial infections and diseases associated therewith | |
ECSP066484A (es) | Compuestos y metodos para el tratamiento de dislipidemia | |
DE69902526D1 (de) | Verbesserung der antibakteriellen wirkung von oxazolidinon durch arginin derivate | |
YU102503A (sh) | Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva | |
AU2003294565A8 (en) | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents | |
ATE510845T1 (de) | Antibakterielle makrozyklen mit substituiertem biphenyl | |
BR0307085A (pt) | Terapia combinada para o tratamento de infecções bacterianas | |
NO20010140D0 (no) | Kjemotakse-inhiberende protein av Staphylo-Coccus (CHIPS) og dets anvendelse | |
DE60137459D1 (de) | Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen | |
AU2003259159A1 (en) | N-aryl-2-oxazolidinones and their derivatives | |
SE0001631D0 (sv) | New use | |
DE60326710D1 (de) | Trizyklische antibakterielle makrolidderivate | |
DE60235538D1 (de) | Glycopeptid-antibiotika | |
WO2003068790A3 (en) | Macrolide antibacterial compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |